Gastric Emptying, Diabetes, and Aging

Clinics in Geriatric Medicine

Volumn 23, Issue 4, 2007, Pages 785-808

  Kuo, Paul ^a   Rayner, Christopher K ^a   Horowitz, Michael ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BACTERIAL INFECTION; DRUG ABSORPTION; FOOD INTAKE; GASTRODUODENAL FUNCTION; GLUCONEOGENESIS; GLUCOSE INTOLERANCE; HUMAN; INSULIN CLEARANCE; INSULIN RESISTANCE; INTESTINE FUNCTION; METABOLIC RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; STOMACH EMPTYING;

AGED; AGING; DIABETES MELLITUS; GASTRIC EMPTYING; HUMANS; INSULIN RESISTANCE;

EID: 34948825388     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.06.009     Document Type: Review

References (218)

1. Russo A., Stevens J.E., Wilson T., et al. Guar attenuates fall in postprandial blood pressure and slows gastric emptying of oral glucose in type 2 diabetes. Dig Dis Sci 48 7 (2003) 1221-1229
2. Gentilcore D., Hausken T., Horowitz M., et al. Measurements of gastric emptying of low- and high-nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects. Neurogastroenterol Motil 18 12 (2006) 1062-1068
3. Dupre J., Behme M.T., and McDonald T.J. Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes. J Clin Endocrinol Metab 89 7 (2004) 3469-3473
4. Kolterman O.G., Gottlieb A., Moyses C., et al. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18 8 (1995) 1179-1182
5. Horowitz M., O'Donovan D., Jones K.L., et al. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19 3 (2002) 177-194
6. Rayner C.K., and Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol 2 10 (2005) 454-462 [quiz: 493]
7. Horowitz M., Su Y.C., Rayner C.K., et al. Gastroparesis: prevalence, clinical significance and treatment. Can J Gastroenterol 15 12 (2001) 805-813
8. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 11 3 (1999) 141-161
9. Gentilcore D., O'Donovan D., Jones K.L., et al. Nutrition therapy for diabetic gastroparesis. Curr Diab Rep 3 5 (2003) 418-426
10. Little T.J., Horowitz M., and Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev 6 4 (2005) 297-306
11. Schmitz O., Brock B., and Rungby J. Amylin agonists: a novel approach in the treatment of diabetes. Diabetes 53 Suppl 3 (2004) S233-S238
12. Desai K.M., Sessa W.C., and Vane J.R. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 351 6326 (1991) 477-479
13. Tack J., Demedts I., Meulemans A., et al. Role of nitric oxide in the gastric accommodation reflex and in meal induced satiety in humans. Gut 51 2 (2002) 219-224
14. Collins P.J., Horowitz M., Cook D.J., et al. Gastric emptying in normal subjects-a reproducible technique using a single scintillation camera and computer system. Gut 24 12 (1983) 1117-1125
15. Rayner C.K., Samsom M., Jones K.L., et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 24 2 (2001) 371-381
16. Bell R.A., Jones-Vessey K., and Summerson J.H. Hospitalizations and outcomes for diabetic gastroparesis in North Carolina. South Med J 95 11 (2002) 1297-1299
17. Gallar P., Oliet A., Vigil A., et al. Gastroparesis: an important cause of hospitalization in continuous ambulatory peritoneal dialysis patients and the role of erythromycin. Perit Dial Int 13 Suppl 2 (1993) S183-S186
18. Kong M.F., Horowitz M., Jones K.L., et al. Natural history of diabetic gastroparesis. Diabetes Care 22 3 (1999) 503-507
19. Phillips W.T., Schwartz J.G., and McMahan C.A. Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med 33 8 (1992) 1496-1500
20. Schwartz J.G., Green G.M., Guan D., et al. Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care 19 5 (1996) 468-471
21. Jones M.P., and Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 98 10 (2003) 2122-2129
22. Koch K.L. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci 44 6 (1999) 1061-1075
23. Samsom M., Roelofs J.M., Akkermans L.M., et al. Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy. Dig Dis Sci 43 3 (1998) 491-496
24. Mearin F., Camilleri M., and Malagelada J.R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 90 6 (1986) 1919-1925
25. Thumshirn M., Bruninga K., and Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 92 9 (1997) 1496-1500
26. Fraser R.J., Horowitz M., Maddox A.F., et al. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis-effects of cisapride. Gut 35 2 (1994) 172-178
27. Mathur R., Pimentel M., Sam C.L., et al. Postprandial improvement of gastric dysrhythmias in patients with type II diabetes: identification of responders and nonresponders. Dig Dis Sci 46 4 (2001) 705-712
28. Asakawa H., Onishi M., Hayashi I., et al. Comparison between coefficient of R-R interval variation and gastric emptying in type 2 diabetes mellitus patients. J Gastroenterol Hepatol 20 9 (2005) 1358-1364
29. Jones K.L., Russo A., Stevens J.E., et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 24 7 (2001) 1264-1269
30. Horvath V.J., Vittal H., Lorincz A., et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of Cajal in murine diabetic gastroparesis. Gastroenterology 130 3 (2006) 759-770
31. Watkins C.C., Sawa A., Jaffrey S., et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 106 3 (2000) 373-384
32. Horvath V.J., Vittal H., and Ordog T. Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach. Diabetes 54 5 (2005) 1528-1533
33. Ordog T., Takayama I., Cheung W.K., et al. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 49 10 (2000) 1731-1739
34. Anitha M., Gondha C., Sutliff R., et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 116 2 (2006) 344-356
35. Forster J., Damjanov I., Lin Z., et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 9 1 (2005) 102-108
36. Ejskjaer N.T., Bradley J.L., Buxton-Thomas M.S., et al. Novel surgical treatment and gastric pathology in diabetic gastroparesis. Diabet Med 16 6 (1999) 488-495
37. Jones K.L., Kong M.F., Berry M.K., et al. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration. Am J Gastroenterol 94 8 (1999) 2074-2079
38. Schvarcz E., Palmer M., Aman J., et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 113 1 (1997) 60-66
39. Fraser R.J., Horowitz M., Maddox A.F., et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33 11 (1990) 675-680
40. Samsom M., Akkermans L.M., Jebbink R.J., et al. Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus. Gut 40 5 (1997) 641-646
41. Russo A., Stevens J.E., Chen R., et al. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 90 8 (2005) 4489-4495
42. Takahashi T., Matsuda K., Kono T., et al. Inhibitory effects of hyperglycemia on neural activity of the vagus in rats. Intensive Care Med 29 2 (2003) 309-311
43. Mizuno Y., and Oomura Y. Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res 307 1-2 (1984) 109-116
44. Liu M., Seino S., and Kirchgessner A.L. Identification and characterization of glucoresponsive neurons in the enteric nervous system. J Neurosci 19 23 (1999) 10305-10317
45. Yeap B.B., Russo A., Fraser R.J., et al. Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects. Diabetes Care 19 8 (1996) 880-882
46. Kong M.F., King P., Macdonald I.A., et al. Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus. Diabetologia 42 3 (1999) 365-372
47. Nathan D.M., Cleary P.A., Backlund J.Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 25 (2005) 2643-2653
48. The Diabetes Control and Complications Trial [DCCT] Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N Engl J Med 329 14 (1993) 977-986
49. UK Prospective Diabetes Study [UKPDS] Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 9131 (1998) 837-853
50. Rayner C.K., and Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?. J Clin Invest 116 2 (2006) 299-302
51. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26 3 (2003) 881-885
52. Beisswenger P., Heine R.J., Leiter L.A., et al. Prandial glucose regulation in the glucose triad: emerging evidence and insights. Endocrine 25 3 (2004) 195-202
53. Gerich J.E. Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 163 11 (2003) 1306-1316
54. Bastyr III E.J., Stuart C.A., Brodows R.G., et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group. Diabetes Care 23 9 (2000) 1236-1241
55. Jones K.L., MacIntosh C., Su Y.C., et al. Guar gum reduces postprandial hypotension in older people. J Am Geriatr Soc 49 2 (2001) 162-167
56. Horowitz M., Jones K.L., Rayner C.K., et al. 'Gastric' hypoglycaemia-an important concept in diabetes management. Neurogastroenterol Motil 18 6 (2006) 405-407
57. Chandalia M., Garg A., Lutjohann D., et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 342 19 (2000) 1392-1398
58. Gentilcore D., Chaikomin R., Jones K.L., et al. Effects of fat on gastric emptying of, and the glycemic, insulin and incretin responses to, a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab 91 6 (2006) 2062-2067
59. Egan J.M., Clocquet A.R., and Elahi D. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 87 3 (2002) 1282-1290
60. Nauck M. Therapeutic potential of glucagon-like peptide 1 in type 2 diabetes. Diabet Med 13 9 Suppl 5 (1996) S39-S43
61. Nauck M.A., and Meier J.J. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul Pept 128 2 (2005) 135-148
62. Thompson R.G., Gottlieb A., Organ K., et al. Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes. Diabet Med 14 7 (1997) 547-555
63. Schwartz J.G., Guan D., Green G.M., et al. Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients. Diabetes Care 17 4 (1994) 255-262
64. Phillips W.T., Schwartz J.G., and McMahan C.A. Reduced postprandial blood glucose levels in recently diagnosed non-insulin-dependent diabetics secondary to pharmacologically induced delayed gastric emptying. Dig Dis Sci 38 1 (1993) 51-58
65. Gonlachanvit S., Hsu C.W., Boden G.H., et al. Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients. Dig Dis Sci 48 3 (2003) 488-497
66. Firth M., and Prather C.M. Gastrointestinal motility problems in the elderly patient. Gastroenterology 122 6 (2002) 1688-1700
67. Kupfer R.M., Heppell M., Haggith J.W., et al. Gastric emptying and small-bowel transit rate in the elderly. J Am Geriatr Soc 33 5 (1985) 340-343
68. Madsen J.L., and Graff J. Effects of ageing on gastrointestinal motor function. Age Ageing 33 2 (2004) 154-159
69. Brogna A., Ferrara R., Bucceri A.M., et al. Influence of aging on gastrointestinal transit time. An ultrasonographic and radiologic study. Invest Radiol 34 5 (1999) 357-359
70. Horowitz M., Maddern G.J., Chatterton B.E., et al. Changes in gastric emptying rates with age. Clin Sci (Lond) 67 2 (1984) 213-218
71. Clarkston W.K., Pantano M.M., Morley J.E., et al. Evidence for the anorexia of aging: gastrointestinal transit and hunger in healthy elderly vs. young adults. Am J Physiol 272 1 Pt 2 (1997) R243-R248
72. Evans M.A., Triggs E.J., Cheung M., et al. Gastric emptying rate in the elderly: implications for drug therapy. J Am Geriatr Soc 29 5 (1981) 201-205
73. Nakae Y., Onouchi H., Kagaya M., et al. Effects of aging and gastric lipolysis on gastric emptying of lipid in liquid meal. J Gastroenterol 34 4 (1999) 445-449
74. Chassagne P., Capet C., Verdonck A., et al. Does age influence the gastric emptying of solids?. Am J Gastroenterol 98 7 (2003) 1659-1661
75. Kao C.H., Lai T.L., Wang S.J., et al. Influence of age on gastric emptying in healthy Chinese. Clin Nucl Med 19 5 (1994) 401-404
76. Moore J.G., Tweedy C., Christian P.E., et al. Effect of age on gastric emptying of liquid-solid meals in man. Dig Dis Sci 28 4 (1983) 340-344
77. O'Donovan D., Hausken T., Lei Y., et al. Effect of aging on transpyloric flow, gastric emptying, and intragastric distribution in healthy humans-impact on glycemia. Dig Dis Sci 50 4 (2005) 671-676
78. Cook C.G., Andrews J.M., Jones K.L., et al. Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. Am J Physiol 273 2 Pt 2 (1997) R755-R761
79. MacIntosh C.G., Andrews J.M., Jones K.L., et al. Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. Am J Clin Nutr 69 5 (1999) 999-1006
80. Shimamoto C., Hirata I., Hiraike Y., et al. Evaluation of gastric motor activity in the elderly by electrogastrography and the (13)C-acetate breath test. Gerontology 48 6 (2002) 381-386
81. MacIntosh C.G., Horowitz M., Verhagen M.A., et al. Effect of small intestinal nutrient infusion on appetite, gastrointestinal hormone release, and gastric myoelectrical activity in young and older men. Am J Gastroenterol 96 4 (2001) 997-1007
82. Levanon D., Zhang M., and Chen J.D. Efficiency and efficacy of the electrogastrogram. Dig Dis Sci 43 5 (1998) 1023-1030
83. Pfaffenbach B., Adamek R.J., Kuhn K., et al. Electrogastrography in healthy subjects. Evaluation of normal values, influence of age and gender. Dig Dis Sci 40 7 (1995) 1445-1450
84. Sturm K., Parker B., Wishart J., et al. Energy intake and appetite are related to antral area in healthy young and older subjects. Am J Clin Nutr 80 3 (2004) 656-667
85. MacIntosh C.G., Morley J.E., Wishart J., et al. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 86 12 (2001) 5830-5837
86. Sturm K., MacIntosh C.G., Parker B.A., et al. Appetite, food intake, and plasma concentrations of cholecystokinin, ghrelin, and other gastrointestinal hormones in undernourished older women and well-nourished young and older women. J Clin Endocrinol Metab 88 8 (2003) 3747-3755
87. Rayner C.K., MacIntosh C.G., Chapman I.M., et al. Effects of age on proximal gastric motor and sensory function. Scand J Gastroenterol 35 10 (2000) 1041-1047
88. Mitsukawa T., Takemura J., Nakazato M., et al. Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load. Diabetes Res Clin Pract 15 2 (1992) 131-134
89. Rigamonti A.E., Pincelli A.I., Corra B., et al. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. J Endocrinol 175 1 (2002) R1-R5
90. Parker B.A., and Chapman I.M. Food intake and ageing-the role of the gut. Mech Ageing Dev 125 12 (2004) 859-866
91. Purnell J.Q., Weigle D.S., Breen P., et al. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab 88 12 (2003) 5747-5752
92. Cryer B., Redfern J.S., Goldschmiedt M., et al. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology 102 4 Pt 1 (1992) 1118-1123
93. Feldman M., and Cryer B. Effects of age on gastric alkaline and nonparietal fluid secretion in humans. Gerontology 44 4 (1998) 222-227
94. Feldman M., Cryer B., McArthur K.E., et al. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 110 4 (1996) 1043-1052
95. Farinati F., Formentini S., Della Libera G., et al. Changes in parietal and mucous cell mass in the gastric mucosa of normal subjects with age: a morphometric study. Gerontology 39 3 (1993) 146-151
96. Hackelsberger A., Platzer U., Nilius M., et al. Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently. Gut 43 4 (1998) 465-469
97. Lee M., Hardman W.E., and Cameron I. Age-related changes in gastric mucosal repair and proliferative activities in rats exposed acutely to aspirin. Gerontology 44 4 (1998) 198-203
98. Lee M. Age-related changes in gastric blood flow in rats. Gerontology 42 5 (1996) 289-293
99. Goldschmiedt M., Barnett C.C., Schwarz B.E., et al. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 101 4 (1991) 977-990
100. Baron J.H. Studies of basal and peak acid output with an augmented histamine test. Gut 4 (1963) 136-144
101. Blackman A.H., Lambert D.L., Thayer W.R., et al. Computed normal values for peak acid output based on age, sex and body weight. Am J Dig Dis 15 9 (1970) 783-789
102. Grossman M.I., Kirsner J.B., and Gillespie I.E. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 45 (1963) 14-26
103. Kinoshita Y., Kawanami C., Kishi K., et al. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 41 4 (1997) 452-458
104. Collen M.J., Abdulian J.D., and Chen Y.K. Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease. Am J Gastroenterol 89 5 (1994) 712-716
105. Katelaris P.H., Seow F., Lin B.P., et al. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 34 8 (1993) 1032-1037
106. Haruma K., Kamada T., Kawaguchi H., et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol 15 3 (2000) 277-283
107. Saltzman J.R., Kowdley K.V., Perrone G., et al. Changes in small-intestine permeability with aging. J Am Geriatr Soc 43 2 (1995) 160-164
108. Meciano Filho J, Carvalho VC, de Souza RR. Nerve cell loss in the myenteric plexus of the human esophagus in relation to age: a preliminary investigation. Gerontology 41(1):18-21.
109. de Souza R.R., Moratelli H.B., Borges N., et al. Age-induced nerve cell loss in the myenteric plexus of the small intestine in man. Gerontology 39 4 (1993) 183-188
110. Gomes O.A., de Souza R.R., and Liberti E.A. A preliminary investigation of the effects of aging on the nerve cell number in the myenteric ganglia of the human colon. Gerontology 43 4 (1997) 210-217
111. Saffrey M.J. Ageing of the enteric nervous system. Mech Ageing Dev 125 12 (2004) 899-906
112. Phillips R.J., and Powley T.L. As the gut ages: timetables for aging of innervation vary by organ in the Fischer 344 rat. J Comp Neurol 434 3 (2001) 358-377
113. Wiley J.W. Aging and neural control of the GI tract: III. Senescent enteric nervous system: lessons from extraintestinal sites and nonmammalian species. Am J Physiol Gastrointest Liver Physiol 283 5 (2002) G1020-G1026
114. Smits G.J., and Lefebvre R.A. Influence of age on responsiveness of rat gastric fundus to agonists and to stimulation of intrinsic nerves. Eur J Pharmacol 223 1 (1992) 97-102
115. Moller N., Gormsen L., Fuglsang J., et al. Effects of aging on insulin secretion and action. Horm Res 60 Suppl 1 (2003) 102-104
116. Meneilly G.S., Ryan A.S., Veldhuis J.D., et al. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals. J Clin Endocrinol Metab 82 12 (1997) 4088-4093
117. Chang A.M., and Halter J.B. Aging and insulin secretion. Am J Physiol Endocrinol Metab 284 1 (2003) E7-E12
118. Chen M., Bergman R.N., Pacini G., et al. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab 60 1 (1985) 13-20
119. Roder M.E., Schwartz R.S., Prigeon R.L., et al. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels. J Clin Endocrinol Metab 85 6 (2000) 2275-2280
120. Jackson R.A., Hawa M.I., Roshania R.D., et al. Influence of aging on hepatic and peripheral glucose metabolism in humans. Diabetes 37 1 (1988) 119-129
121. American Diabetes Association. Standards in Medical Care in Diabetes-2006. 2006.
122. Bruce D.G., Davis W.A., and Davis T.M. Glycemic control in older subjects with type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc 48 11 (2000) 1449-1453
123. Porksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia 45 1 (2002) 3-20
124. Ahren B., and Pacini G. Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J Clin Endocrinol Metab 83 9 (1998) 3350-3356
125. Pacini G., Beccaro F., Valerio A., et al. Reduced beta-cell secretion and insulin hepatic extraction in healthy elderly subjects. J Am Geriatr Soc 38 12 (1990) 1283-1289
126. Dechenes C.J., Verchere C.B., Andrikopoulos S., et al. Human aging is associated with parallel reductions in insulin and amylin release. Am J Physiol 275 5 Pt 1 (1998) E785-E791
127. Fritsche A., Madaus A., Stefan N., et al. Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans. Diabetes 51 Suppl 1 (2002) S234-S239
128. Gumbiner B., Polonsky K.S., Beltz W.F., et al. Effects of aging on insulin secretion. Diabetes 38 12 (1989) 1549-1556
129. Scheen A.J., Sturis J., Polonsky K.S., et al. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging. Diabetologia 39 5 (1996) 564-572
130. Chiu K.C., Lee N.P., Cohan P., et al. Beta cell function declines with age in glucose tolerant Caucasians. Clin Endocrinol (Oxf) 53 5 (2000) 569-575
131. Meneilly G.S., Veldhuis J.D., and Elahi D. Deconvolution analysis of rapid insulin pulses before and after six weeks of continuous subcutaneous administration of glucagon-like peptide-1 in elderly patients with type 2 diabetes. J Clin Endocrinol Metab 90 11 (2005) 6251-6256
132. Meneilly G.S., Ryan A.S., Minaker K.L., et al. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin. J Clin Endocrinol Metab 83 8 (1998) 2925-2932
133. Meneilly G.S., Demuth H.U., McIntosh C.H., et al. Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabet Med 17 5 (2000) 346-350
134. Elahi D., Andersen D.K., Muller D.C., et al. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes 33 10 (1984) 950-957
135. O'Meara N.M., Sturis J., Van Cauter E., et al. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest 92 1 (1993) 262-271
136. Ferrannini E., Vichi S., Beck-Nielsen H., et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45 7 (1996) 947-953
137. O'Shaughnessy I.M., Kasdorf G.M., Hoffmann R.G., et al. Does aging intensify the insulin resistance of human obesity?. J Clin Endocrinol Metab 74 5 (1992) 1075-1081
138. Basu R., Breda E., Oberg A.L., et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 52 7 (2003) 1738-1748
139. Pacini G., Valerio A., Beccaro F., et al. Insulin sensitivity and beta-cell responsivity are not decreased in elderly subjects with normal OGTT. J Am Geriatr Soc 36 4 (1988) 317-323
140. Boden G., Chen X., DeSantis R.A., et al. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 16 5 (1993) 728-733
141. Coon P.J., Rogus E.M., Drinkwater D., et al. Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab 75 4 (1992) 1125-1132
142. Carey D.G., Jenkins A.B., Campbell L.V., et al. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45 5 (1996) 633-638
143. O'Shaughnessy I.M., Myers T.J., Stepniakowski K., et al. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 26 1 (1995) 186-192
144. Cefalu W.T., Wang Z.Q., Werbel S., et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44 7 (1995) 954-959
145. Utzschneider K.M., Carr D.B., Hull R.L., et al. Impact of intra-abdominal fat and age on insulin sensitivity and beta-cell function. Diabetes 53 11 (2004) 2867-2872
146. Gabriely I., Ma X.H., Yang X.M., et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 51 10 (2002) 2951-2958
147. Colombo M., Kruhoeffer M., Gregersen S., et al. Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis. Metabolism 55 1 (2006) 43-52
148. Meneilly G.S., Elahi D., Minaker K.L., et al. Impairment of noninsulin-mediated glucose disposal in the elderly. J Clin Endocrinol Metab 68 3 (1989) 566-571
149. Petersen K.F., Befroy D., Dufour S., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300 5622 (2003) 1140-1142
150. Fulop Jr. T., Nagy J.T., Worum I., et al. Glucose intolerance and insulin resistance with aging-studies on insulin receptors and post-receptor events. Arch Gerontol Geriatr 6 2 (1987) 107-115
151. Bunout D., Barrera G., de la Maza P., et al. Seasonal variation in insulin sensitivity in healthy elderly people. Nutrition 19 4 (2003) 310-316
152. Gravholt C.H., Holck P., Nyholm B., et al. No seasonal variation of insulin sensitivity and glucose effectiveness in men. Metabolism 49 1 (2000) 32-38
153. Chiu K.C., Chu A., Go V.L., et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 5 (2004) 820-825
154. Meneilly G.S., and Elahi D. Metabolic alterations in middle-aged and elderly lean patients with type 2 diabetes. Diabetes Care 28 6 (2005) 1498-1499
155. Meneilly G.S., Elliott T., Tessier D., et al. NIDDM in the elderly. Diabetes Care 19 12 (1996) 1320-1325
156. Kim J., Choi S., Kong B., et al. Insulin secretion and sensitivity during oral glucose tolerance test in Korean lean elderly women. J Korean Med Sci 16 5 (2001) 592-597
157. Juneja R., and Palmer J.P. Type 1 1/2 diabetes: myth or reality?. Autoimmunity 29 1 (1999) 65-83
158. Arner P., Pollare T., and Lithell H. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34 7 (1991) 483-487
159. Chan W.B., Tong P.C., Chow C.C., et al. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients. Diabet Med 21 4 (2004) 349-353
160. Tentolouris N., Grapsas E., Stambulis E., et al. Impact of body mass on autonomic function in persons with type 2 diabetes. Diabetes Res Clin Pract 46 1 (1999) 29-33
161. Straub R.H., Thum M., Hollerbach C., et al. Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 17 11 (1994) 1290-1294
162. Arvanitakis Z., Wilson R.S., Li Y., et al. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care 29 3 (2006) 560-565
163. Hassing L.B., Hofer S.M., Nilsson S.E., et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 33 4 (2004) 355-361
164. Peila R., Rodriguez B.L., and Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51 4 (2002) 1256-1262
165. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 26 Suppl 1 (2005) 26-30
166. Wu J.H., Haan M.N., Liang J., et al. Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13 5 (2003) 369-376
167. Messier C., Desrochers A., and Gagnon M. Effect of glucose, glucose regulation, and word imagery value on human memory. Behav Neurosci 113 3 (1999) 431-438
168. Gradman T.J., Laws A., Thompson L.W., et al. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 41 12 (1993) 1305-1312
169. Meneilly G.S., Cheung E., Tessier D., et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 48 4 (1993) M117-M121
170. Mussell M., Hewer W., Kulzer B., et al. Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes. Diabet Med 21 11 (2004) 1253-1256
171. Abbatecola A.M., Rizzo M.R., Barbieri M., et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 67 2 (2006) 235-240
172. Araki Y., Nomura M., Tanaka H., et al. MRI of the brain in diabetes mellitus. Neuroradiology 36 2 (1994) 101-103
173. den Heijer T., Vermeer S.E., van Dijk E.J., et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46 12 (2003) 1604-1610
174. Park S.W., Goodpaster B.H., Strotmeyer E.S., et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes 55 6 (2006) 1813-1818
175. Nimmo W.S. Drugs, diseases and altered gastric emptying. Clin Pharmacokinet 1 3 (1976) 189-203
176. Lamy P.P. Comparative pharmacokinetic changes and drug therapy in an older population. J Am Geriatr Soc 30 Suppl 11 (1982) S11-S19
177. Groop L.C., Luzi L., DeFronzo R.A., et al. Hyperglycaemia and absorption of sulphonylurea drugs. Lancet 2 8655 (1989) 129-130
178. Nimmo W.S., Heading R.C., Wilson J., et al. Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol 2 6 (1975) 509-513
179. Gainsborough N., Maskrey V.L., Nelson M.L., et al. The association of age with gastric emptying. Age Ageing 22 1 (1993) 37-40
180. Divoll M., Ameer B., Abernethy D.R., et al. Age does not alter acetaminophen absorption. J Am Geriatr Soc 30 4 (1982) 240-244
181. Divoll M., Greenblatt D.J., Ameer B., et al. Effect of food on acetaminophen absorption in young and elderly subjects. J Clin Pharmacol 22 11-12 (1982) 571-576
182. Kay L. Prevalence, incidence and prognosis of gastrointestinal symptoms in a random sample of an elderly population. Age Ageing 23 2 (1994) 146-149
183. Talley N.J., Evans J.M., Fleming K.C., et al. Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly. Dig Dis Sci 40 6 (1995) 1345-1350
184. O'Riordan T.G., Tobin A., and O'Morain C. Helicobacter pylori infection in elderly dyspeptic patients. Age Ageing 20 3 (1991) 189-192
185. Merle L., Laroche M.L., Dantoine T., et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 22 5 (2005) 375-392
186. Chiasson J.L., Josse R.G., Gomis R., et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 9323 (2002) 2072-2077
187. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 6 (2002) 393-403
188. Meyer K.A., Kushi L.H., Jacobs Jr. D.R., et al. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71 4 (2000) 921-930
189. Kim H.J., Lee J.S., and Kim C.K. Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. Eur J Appl Physiol 93 3 (2004) 353-358
190. Franz M.J., Bantle J.P., Beebe C.A., et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25 1 (2002) 148-198
191. Sigal R.J., Kenny G.P., Wasserman D.H., et al. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29 6 (2006) 1433-1438
192. Pontiroli A.E., Calderara A., Pacchioni M., et al. Insulin requirement in elderly patients with non-insulin dependent diabetes mellitus (NIDDM). Aging (Milano) 1 2 (1989) 147-152
193. Schwartz A.V., Hillier T.A., Sellmeyer D.E., et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 25 10 (2002) 1749-1754
194. Schwartz A.V., Sellmeyer D.E., Ensrud K.E., et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 86 1 (2001) 32-38
195. Matyka K., Evans M., Lomas J., et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 20 2 (1997) 135-141
196. Oiknine R., and Mooradian A.D. Drug therapy of diabetes in the elderly. Biomed Pharmacother 57 5-6 (2003) 231-239
197. Meneilly G.S., Greig N., Tildesley H., et al. Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 26 10 (2003) 2835-2841
198. Meneilly G.S., McIntosh C.H., Pederson R.A., et al. Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes. Diabetes Care 24 5 (2001) 964-965
199. Meneilly G.S., McIntosh C.H., Pederson R.A., et al. Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes. Diabetes Care 24 11 (2001) 1951-1956
200. Edwards C.M., Stanley S.A., Davis R., et al. Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab 281 1 (2001) E155-E161
201. Kolterman O.G., Buse J.B., Fineman M.S., et al. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 88 7 (2003) 3082-3089
202. Meneilly G.S., McIntosh C.H., Pederson R.A., et al. Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes. J Gerontol A Biol Sci Med Sci 56 11 (2001) M681-M685
203. Knop F.K., Vilsboll T., Larsen S., et al. No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis. Diabetes Care 26 9 (2003) 2581-2587
204. Linnebjerg H., Kothare P.A., Skrivanek Z., et al. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes. Diabet Med 23 3 (2006) 240-245
205. Nauck M.A., Niedereichholz U., Ettler R., et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 273 5 Pt 1 (1997) E981-E988
206. O'Donovan D., Feinle-Bisset C., Jones K., et al. Idiopathic and Diabetic Gastroparesis. Curr Treat Options Gastroenterol 6 4 (2003) 299-309
207. Crowell M.D., Mathis C., Schettler V.A., et al. The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus. Neurogastroenterol Motil 17 5 (2005) 738-743
208. Asakawa H., Hayashi I., Fukui T., et al. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy. Diabetes Res Clin Pract 61 3 (2003) 175-182
209. Murray C.D., Martin N.M., Patterson M., et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 54 12 (2005) 1693-1698
210. Mansi C., Savarino V., Vigneri S., et al. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. Am J Gastroenterol 90 11 (1995) 1989-1993
211. Melga P., Mansi C., Ciuchi E., et al. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 20 1 (1997) 55-58
212. Bromer M.Q., Friedenberg F., Miller L.S., et al. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 61 7 (2005) 833-839
213. Forster J., Sarosiek I., Lin Z., et al. Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg 186 6 (2003) 690-695
214. Lin Z., Forster J., Sarosiek I., et al. Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation. Diabetes Care 27 5 (2004) 1071-1076
215. Lin Z., Sarosiek I., Forster J., et al. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 18 1 (2006) 18-27
216. van der Voort I.R., Becker J.C., Dietl K.H., et al. Gastric electrical stimulation results in improved metabolic control in diabetic patients suffering from gastroparesis. Exp Clin Endocrinol Diabetes 113 1 (2005) 38-42
217. Tonini M., De Ponti F., Di Nucci A., et al. Review article: cardiac adverse effects of gastrointestinal prokinetics. Aliment Pharmacol Ther 13 12 (1999) 1585-1591
218. Edelbroek M.A., Horowitz M., Wishart J.M., et al. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med 34 4 (1993) 582-588